T. van der Molen (Groningen, The Netherlands), H. Pinnock (Whitstable, United Kingdom)
General practice and office spirometry in asthma and COPD: preliminary data from the prospective, randomised, comparative ²SPACE² Italian study
C. F. Donner, M. Lusuardi, F. De Benedetto, P. L. Paggiaro, C. M. Sanguinetti, A. Poli, P. Ferri, G. Brazzola (Veruno, Correggio, Chieti, Pisa, Roma, Milano, Italy)
|  |
A technical and functional assessment of office spirometry devices. A multicentre comparative study
G. Liistro, C. Vanwelde, W. Vincken, J. Vandevoorde, G. M. Verleden, J. Buffels, COPD Advisory Board (Brussels, Leuven, Genval, Belgium)
| |
Interpretating the results of spirometry and anamnesis into a diagnose and an advice for treatment: validation and reliability
A. Lucas, F. Smeenk, I. Smeele (Maastricht, Eindhoven, Breda, The Netherlands)
| |
Electronic data collection as an aid to quantification of the burden of COPD in general practice
M. L. Hazell, T. L. Frank, M. D. Spencer, D. T. Williams, P. I. Frank (Manchester, Greenford, Uxbridge, United Kingdom)
| |
Gaps in assessing women at risk for COPD in a multidisciplinary women‘s health program; still missing the connection
A. Day, K. Hildebrand, N. Sood (Toronto, Winnipeg, Canada)
| |
Cilomilast decreases exacerbations and maintains lung function in patients with poorly reversible COPD
S. Lim, J. Zhu, P. Lake (Greenford, United Kingdom)
| |
Preference for novel soft mist inhaler over pMDI in patients with COPD
W. Schürmann, M. Barczok, W. Timmer, H. P. Pfaff, R. Hodder (Marburg, Ulm, Ingelheim, Germany; Ottawa, Canada)
| |
Improvement in dyspnea with fluticasone/salmeterol compared with salmeterol or ipratropium in patients with COPD
K. Knobil, K. Merchant, A. Emmett, C. Kalberg (RTP, United States Of America)
| |
COPD patients generate significantly different peak inspiratory flows (PIF) through two different dry powder inhalers (DPI)
K. Richter, B. Ellers-Lenz, T. D. Nguyen, U. Munzel, J. Maus, H. Magnussen (Großhansdorf, Offenbach, Frankfurt, Germany)
| |
A comparison of fluticasone/salmeterol (FSC) and ipratropium/albuterol (IB/ALB) in patients with COPD: lung function and symptoms
K. Knobil, C. Kalberg, K. Merchant, A. Emmett (Research Triangle Park, United States Of America)
| |
Lung function and symptom improvement with fluticasone/salmeterol and ipratropium/albuterol in albuterol responsive and non-responsive COPD patients
K. Knobil, A. Emmett, K. Merchant, C. Kalberg (Research Triangle Park, United States Of America)
| |
Impact of definition when assessing the cumulative incidence of exacerbation amongst a cohort of primary care COPD patients
J. F. O‘Reilly, A. E. Williams, L. Rice, K. Holt (Blackpool, Greenford, Poulton, United Kingdom)
| |
Incidence and impact of healthcare defined exacerbation amongst a cohort of primary care COPD patients
J. F. O‘Reilly, A. E. Williams, L. Rice, K. Olt (Blackpool, Greenford, Poulton, United Kingdom)
| |
COPD exacerbations in patients with chronic obstructive pulmonary disease in general practice in Ireland
J. C. Edwards, D. Massey, J. O‘Riordan (Dublin, Blarney, Ireland; Bracknell, United Kingdom)
| |
An evaluation of exacerbations in COPD
R. Kessler, C. G. Löfdahl, G. Tornling, E. Ståhl (Strasbourg, France; Lund, Sweden)
| |
Prediction of exacerbations (EXAC) by evaluation of patient characteristics and previous events in COPD
D. Niewoehner, K. Rice, W. Kuschner, A. Sharafkhaneh, C. Cassino, L. Korducki, S. Kesten (Minneapolis, Palo Alto, Houston, Ridgefield, United States Of America)
| |
A multidisciplinary approach in the global treatment of severe COPD reduces hospitalisation during 3 years in a rural part of the province of Quebec, Canada
R. Audet, M. F. Otis, F. Cyr, M. E. Doucet (Maria, Canada)
| |
The role of primary care physicians in education of patients with chronic obstructive pulmonary disease
V. Petrovic, S. V. Raljevic (Belgrade, Serbia & Montenegro)
| |
Gaps in assessing women at risk for COPD in a multidisciplinary women‘s health program; improving the connection
A. Day, S. Vigod (Toronto, Canada)
| |
COPD in primary care - international survey DSP III (patient population description)
H. Mullerova, M. P. Benford, S. W. Kay, D. J. Kourtney (Greenford, Macclesfield, United Kingdom)
| |